Monitoring free light chains in serum using mass spectrometry

Clinical Chemistry and Laboratory Medicine

Volumn 54, Issue 6, 2016, Pages 1073-1083

  Barnidge, David R ^a   Dispenzieri, Angela ^a   Merlini, Giampaolo ^b   Katzmann, Jerry A ^a   Murray, David L ^a  

^a MAYO CLINIC   (United States)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

free light chains; mass spectrometry; microflow LC ESI Q TOF MS; monoclonal; ;

Indexed keywords

IMMUNOGLOBULIN; PARAPROTEIN; ADALIMUMAB; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN;

AMYLOIDOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISULFIDE BOND; HUMAN; LIGHT CHAIN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEASUREMENT; MONITORING; MULTIPLE MYELOMA; PLASMA CELL; PLASMA CELL DYSCRASIA; PRIORITY JOURNAL; SERUM; BLOOD; ELECTROSPRAY MASS SPECTROMETRY; IMMUNOLOGY; URINE;

ADALIMUMAB; AMYLOIDOSIS; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84969871849     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2015-0917     Document Type: Article

References (26)

1. Brebner JA, Stockley RA. Polyclonal free light chains: A biomarker of inflammatory disease or treatment target F1000 Med Rep 2013;5:4.
2. Bradwell AR, Carr-Smith HD, Mead GP, Tang LX, Showell PJ, Drayson MT, et al. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem 2001;47:673-80.
3. Dispenzieri A, Kyle R, Merlini G, Miguel JS, Ludwig H, Hajek R, et al. International myeloma working group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia 2009;23:215-24.
4. Barnidge DR, Dasari S, Botz CM, Murray DH, Snyder MR, Katzmann JA, et al. Using mass spectrometry to monitor monoclonal immunoglobulins in patients with a monoclonal gammopathy. J Proteome Res 2014;13:1419-27.
5. Botz CM, Barnidge DR, Murray DL, Katzmann JA. Detecting monoclonal light chains in urine: microLC-ESI-Q-TOF mass spectrometry compared to immunofixation electrophoresis. Br J Haematol 2014;167:437-8.
6. Bondarenko PV, Second TP, Zabrouskov V, Makarov AA, Zhang Z. Mass measurement and top-down HPLC/MS analysis of intact monoclonal antibodies on a hybrid linear quadrupole ion trap-Orbitrap mass spectrometer. J Am Soc Mass Spectrom 2009;20:1415-24.
7. Ren D, Pipes GD, Hambly D, Bondarenko PV, Treuheit MJ, Gadgil HS. Top-down N-terminal sequencing of immunoglobulin subunits with electrospray ionization time of flight mass spectrometry. Anal Biochem 2009;384:42-8.
8. Zhang Z, Pan H, Chen X. Mass spectrometry for structural characterization of therapeutic antibodies. Mass Spectrom Rev 2009;28:147-76.
9. Zhang Z, Shah B. Characterization of variable regions of monoclonal antibodies by top-down mass spectrometry. Anal Chem 2007;79:5723-9.
10. Tsybin YO, Fornelli L, Stoermer C, Luebeck M, Parra J, Nallet S, et al. Structural analysis of intact monoclonal antibodies by electron transfer dissociation mass spectrometry. Anal Chem 2011;83:8919-27.
11. Fornelli L, Damoc E, Thomas PM, Kelleher NL, Aizikov K, Denisov E, et al. Analysis of intact monoclonal antibody IgG1 by electron transfer dissociation Orbitrap FTMS. Mol Cell Proteomics 2012;11:1758-67.
12. Bergen HR, 3rd, Abraham RS, Johnson KL, Bradwell AR, Naylor S. Characterization of amyloidogenic immunoglobulin light chains directly from serum by on-line immunoaffinity isolation. Biomed Chromatogr 2004;18:191-201.
13. Vrana JA, Gamez JD, Plummer TB, Bergen HR, Dogan A. Identification of amyloid proteins in formalin fixed paraffin embedded biopsy specimens by a novel method based on mass spectrometry following laser dissection and capture. Lab Invest 2007;87:356a-a.
14. Vrana JA, Gamez JD, Madden BJ, Theis JD, Bergen HR, 3rd, Dogan A. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood 2009;114:4957-9.
15. Brambilla F, Lavatelli F, Di Silvestre D, Valentini V, Rossi R, Palladini G, et al. Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue. Blood 2012;119:1844-7.
16. Dasari S, Theis JD, Vrana JA, Zenka RM, Zimmermann MT, Kocher JP, et al. Clinical proteome informatics workbench detects pathogenic mutations in hereditary amyloidoses. J Proteome Res 2014;13:2352-8.
17. Lavatelli F, Brambilla F, Valentini V, Rognoni P, Casarini S, Di Silvestre D, et al. A novel approach for the purification and proteomic analysis of pathogenic immunoglobulin free light chains from serum. Biochim Biophys Acta 2011;1814:409-19.
18. Lavatelli F, Perlman DH, Spencer B, Prokaeva T, McComb ME, Theberge R, et al. Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. Mol Cell Proteomics 2008;7:1570-83.
19. Lim A, Wally J, Walsh MT, Skinner M, Costello CE. Identification and location of a cysteinyl posttranslational modification in an amyloidogenic kappa1 light chain protein by electrospray ionization and matrix-assisted laser desorption/ionization mass spectrometry. Anal Biochem 2001;295:45-56.
20. Connors LH, Jiang Y, Budnik M, Theberge R, Prokaeva T, Bodi KL, et al. Heterogeneity in primary structure, post-translational modifications, and germline gene usage of nine full-length amyloidogenic kappa1 immunoglobulin light chains. Biochemistry 2007;46:14259-71.
21. Vila-Rico M, Colome-Calls N, Martin-Castel L, Gay M, Azorin S, Vilaseca M, et al. Quantitative analysis of post-translational modifications in human serum transthyretin associated with familial amyloidotic polyneuropathy by targeted LC-MS and intact protein MS. J Proteomics 2015;127:234-46.
22. Scotcher J, Bythell BJ, Marshall AG. Unequivocal determination of site-specific protein disulfide bond reduction potentials by top-down FTICR MS: Characterization of the N-and C-terminal redox-active sites in human thioredoxin 1. Anal Chem 2013;85:9164-72.
23. Barr JR, Maggio VL, Patterson DG, Jr, Cooper GR, Henderson LO, Turner WE, et al. Isotope dilution-mass spectrometric quantification of specific proteins: Model application with apolipoprotein A-1. Clin Chem 1996;42:1676-82.
24. Barnidge DR, Dratz EA, Martin T, Bonilla LE, Moran LB, Lindall A. Absolute quantification of the G protein-coupled receptor rhodopsin by LC/MS/MS using proteolysis product peptides and synthetic peptide standards. Anal Chem 2003;75:445-51.
25. Gerber SA, Rush J, Stemman O, Kirschner MW, Gygi SP. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem ms. Proc Natl Acad Sci USA 2003;100:6940-5.
26. Barnidge DR, Goodmanson MK, Klee GG, Muddiman DC. Absolute quantification of the model biomarker prostatespecific antigen in serum by LC-MS/MS using protein cleavage and isotope dilution mass spectrometry. J Proteome Res 2004;3:644-52.